Highlights
ASX: IMU       IMUGENE LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.10   -0.01 (9.09%)  0.10 - 0.115  9,363,461

Overview

 
Avg Volume (4 weeks):10,188,485
4 Weeks Range:0.10 - 0.125
4 Weeks Price Volatility (%):
0.00%
52 Weeks Range:0.016 - 0.14
52 Weeks Price Volatility (%):
67.74%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Imugene Limited is an immuno-oncology focused biopharmaceutical company. The Company is engaged in the research and development of human epidermal growth factor receptor 2 positive (HER2 +ve), and gastric and breast cancer vaccines. The Company is also engaged in the research, development and commercialization of health technologies. HER-Vaxx is a cancer immunotherapy designed to treat tumors that over-express the HER-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers. HER-Vaxx has completed a Phase I clinical trial with over 10 HER-2 positive patients with metastatic breast cancer. It was shown in pre-clinical studies and in one Phase 1 study to stimulate a potent polyclonal antibody response to HER-2/neu. HER-Vaxx has stimulated the production of HER-2 antibodies in early-stage cancer patients enrolled in the initial clinical trial. The Company is also developing mimotope-based immunotherapies against validated and oncology targets.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

364  1060  615  1981 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 HWK 0.049+0.01 
 BPH 0.235+0.025 
 DHR 0.0040.00 
 CCE 0.002-0.001 
 BUY 0.042+0.007 
 MRQ 0.0170.00 
 CWL 0.0370.00 
 RAG 0.0110.00 
 88E 0.009-0.001 
 SYA 0.045-0.003